TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Sonic Healthcare Limited ( (AU:SHL) ) is now available.
Sonic Healthcare Limited has announced the appointment of James Pacey Newcombe as a director, effective November 20, 2025. As part of his role, Newcombe holds various unlisted options over ordinary shares in the company, which are part of the Sonic Healthcare Limited Employee Option Plan. This appointment and the associated options indicate a strategic move to align the interests of the director with the long-term goals of the company, potentially impacting its governance and operational strategies.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$23.50 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, primarily focusing on providing laboratory and radiology services. The company is known for its comprehensive diagnostic services and has a significant presence in the global healthcare market.
Average Trading Volume: 1,723,497
Technical Sentiment Signal: Sell
Current Market Cap: A$10.62B
Find detailed analytics on SHL stock on TipRanks’ Stock Analysis page.